Hypothesis

The magnitude of the pupillary light reflex (PLR) elicited by a brief, standardized 480 nm light pulse upon waking predicts the size of the circadian phase advance produced by a subsequent morning light exposure session.

Mechanistic Basis

Intrinsically photosensitive retinal ganglion cells (ipRGCs) expressing melanopsin drive two parallel pathways: (1) projection to the suprachiasmatic nucleus (SCN) that mediates melatonin suppression and phase shifting, and (2) projection to the olivary pretectal nucleus that governs the PLR. Individual differences in ipRGC melanopsin content or coupling efficiency therefore covary with both PLR amplitude and circadian light sensitivity. This predicts a positive correlation between PLR response strength and the degree of phase advance achieved after a fixed dose of morning light.

Testable Predictions

1. Participants with larger PLR constriction amplitudes (≥ 0.3 mm) to a 100 ms 480 nm pulse will show ≥ 15 min greater salivary DLMO advance after 30 min of 10 000 lux blue‑enriched light than those with smaller amplitudes (≤ 0.15 mm).
2. The PLR‑phase advance relationship will hold across chronotypes after adjusting for baseline DLMO.
3. Blocking melanopsin signaling pharmacologically (e.g., with intravitreal melanopsin antisense oligonucleotides in an animal model) will diminish both PLR amplitude and light‑induced phase shifts proportionally.

Methods Outline

• Sample: 60 healthy adults aged 18‑35, stratified by self‑reported chronotype (early, intermediate, late).
• Baseline: Dim‑light melatonin onset (DLMO) assessed via hourly salivary samples under < 5 lux conditions.
• PLR Measurement: Immediately after wake (within 5 min), deliver a 100 ms 480 nm LED pulse (≈ 1 log photons cm⁻² s⁻¹) via a head‑mounted gaze‑stable stimulator; record pupil diameter with infrared video at 200 Hz; compute peak constriction amplitude.
• Light Intervention: 30 min of 10 000 lux blue‑enriched (≈ 460 nm peak) light from a light box positioned at eye level, beginning within the first hour after wake.
• Post‑intervention DLMO: Repeat salivary melatonin assay 24 h later under identical dim‑light conditions.
• Analysis: Linear regression of PLR amplitude predicting ΔDLMO, controlling for age, sex, baseline DLMO, and chronotype; test interaction term for chronotype.

Potential Implications

If validated, PLR offers a rapid, non‑invasive biomarker that could be integrated into consumer wearables (e.g., smartwatch‑based pupillometry via ambient light sensors and front‑camera eye tracking) to provide real‑time feedback on individual circadian light sensitivity. This would enable personalized dosing of morning light—adjusting intensity or duration based on predicted phase‑shift capacity—thereby reducing the high inter‑individual variability currently limiting circadian‑based interventions.